Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.57M Buy
31,209
+1,210
+4% +$219K 1.17% 36
2026
Q1
$4.41M Buy
29,999
+784
+3% +$127K 1.23% 34
2025
Q4
$5.69M Sell
29,215
-3,481
-11% -$829K 1.59% 27
2025
Q3
$9.2M Sell
32,696
-5,200
-14% -$1.32M 2.59% 12
2025
Q2
$8.29M Sell
37,896
-4,267
-10% -$689K 2.47% 12
2025
Q1
$5.89M Buy
42,163
+1,657
+4% +$270K 1.9% 20
2024
Q4
$6.75M Buy
40,506
+773
+2% +$137K 2.07% 17
2024
Q3
$6.77M Buy
39,733
+477
+1% +$69.1K 2.21% 14
2024
Q2
$5.54M Buy
39,256
+3,377
+9% +$419K 1.89% 22
2024
Q1
$4.51M Buy
35,879
+4,011
+13% +$459K 1.63% 29
2023
Q4
$3.36M Buy
+31,868
New +$3.48M 1.28% 34

Other funds holding ORCL

Legacy CG's ORCL Position: Q2 2026 in Review

Legacy CG increased its Oracle (ORCL) stake by 4% in Q2 2026, buying an estimated $219K and bringing the position to 31,209 shares worth $4.57M. The position accounts for 1.17% of the portfolio, ranked #36.

Legacy CG first reported a position in ORCL in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.2M in Q3 2025. 1,558 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Legacy CG held 31,209 shares of Oracle worth $4.57M as of Q2 2026.
  • Legacy CG bought 1,210 Oracle shares in Q2 2026, an estimated $219K.
  • Oracle made up 1.17% of Legacy CG's portfolio in Q2 2026, its #36 holding.
  • Legacy CG first reported a position in Oracle in Q4 2023 and has held it in 11 quarters since.
  • Legacy CG's Oracle position peaked at $9.2M in Q3 2025.
  • 1,558 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Legacy CG's 13F filing for Q2 2026, filed 22 Jul 2026.